| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing vaccine inequities among Ukrainian refugees
|
Hill, Matilda
|
|
|
22 |
7 |
p. 935-936
|
artikel
|
| 2 |
Antifungal therapy for chronic pulmonary aspergillosis
|
Warris, Adilia
|
|
|
22 |
7 |
p. 924-926
|
artikel
|
| 3 |
Antimicrobial resistance data, frugal sequencing, and low-income countries in Africa
|
Aruhomukama, Dickson
|
|
|
22 |
7 |
p. 933-934
|
artikel
|
| 4 |
A step closer to legalised supervised drug use in California
|
Burki, Talha
|
|
|
22 |
7 |
p. 951-952
|
artikel
|
| 5 |
Being heard on all-oral therapy for resistant tuberculosis
|
Furin, Jennifer
|
|
|
22 |
7 |
p. 923-924
|
artikel
|
| 6 |
Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases
|
Lange, Christoph
|
|
|
22 |
7 |
p. e178-e190
|
artikel
|
| 7 |
Correction to Lancet Infect Dis 2022; published online May 24. https://doi.org/10.1016/S1473-3099(22)00228-6
|
|
|
|
22 |
7 |
p. e177
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2022; published online May 24. https://doi.org/10.1016/S1473-3099(22)00228-6
|
|
|
|
22 |
7 |
p. e177
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2022; published online May 17. https://doi.org/10.1016/S1473-3099(22)00149-9
|
|
|
|
22 |
7 |
p. e177
|
artikel
|
| 10 |
COVID-19, haemophagocytic lymphohistiocytosis, and infection-induced cytokine storm syndromes
|
Spaner, Caroline
|
|
|
22 |
7 |
p. 937-938
|
artikel
|
| 11 |
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
|
Kirsebom, Freja C M
|
|
|
22 |
7 |
p. 931-933
|
artikel
|
| 12 |
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
|
Menni, Cristina
|
|
|
22 |
7 |
p. 1002-1010
|
artikel
|
| 13 |
Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study
|
Wang, Bing
|
|
|
22 |
7 |
p. 1011-1020
|
artikel
|
| 14 |
Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study
|
Abara, Winston E
|
|
|
22 |
7 |
p. 1021-1029
|
artikel
|
| 15 |
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India
|
Sehgal, Inderpaul S
|
|
|
22 |
7 |
p. 1052-1061
|
artikel
|
| 16 |
Feasibility of gonorrhoea vaccination among men who have sex with men in England
|
Shen, Mingwang
|
|
|
22 |
7 |
p. 921-923
|
artikel
|
| 17 |
FIND documents dramatic reduction in COVID-19 testing
|
Usher, Ann Danaiya
|
|
|
22 |
7 |
p. 949
|
artikel
|
| 18 |
Global monkeypox outbreak
|
Venkatesan, Priya
|
|
|
22 |
7 |
p. 950
|
artikel
|
| 19 |
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
|
Blom, Kim
|
|
|
22 |
7 |
p. 943-945
|
artikel
|
| 20 |
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
|
Smolenov, Igor
|
|
|
22 |
7 |
p. 990-1001
|
artikel
|
| 21 |
Implications of COVID-19 vaccine effectiveness waning for public health
|
Odone, Anna
|
|
|
22 |
7 |
p. 918-919
|
artikel
|
| 22 |
Infectious diseases surveillance update
|
Islam, Tanzina
|
|
|
22 |
7 |
p. 952
|
artikel
|
| 23 |
Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis
|
Sherwood, Emma
|
|
|
22 |
7 |
p. 1076-1088
|
artikel
|
| 24 |
Is the end of gonorrhoea in sight?
|
Ong, Jason J
|
|
|
22 |
7 |
p. 919-921
|
artikel
|
| 25 |
Mediastinitis associated with a subcutaneous abscess in the chest of a toddler
|
Matsumura, Osamu
|
|
|
22 |
7 |
p. 1089
|
artikel
|
| 26 |
Modelling results on the impact of COVID-19 testing in schools
|
Dyson, Louise
|
|
|
22 |
7 |
p. 915-916
|
artikel
|
| 27 |
Monkeypox: a neglected old foe
|
The Lancet Infectious Diseases,
|
|
|
22 |
7 |
p. 913
|
artikel
|
| 28 |
Monkeypox outbreaks outside endemic regions: scientific and social priorities
|
Zumla, Alimuddin
|
|
|
22 |
7 |
p. 929-931
|
artikel
|
| 29 |
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
|
Yamasoba, Daichi
|
|
|
22 |
7 |
p. 942-943
|
artikel
|
| 30 |
Non-typhoidal salmonella invasive infections in China
|
Hu, Yanyan
|
|
|
22 |
7 |
p. 939
|
artikel
|
| 31 |
Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis
|
Whittles, Lilith K
|
|
|
22 |
7 |
p. 1030-1041
|
artikel
|
| 32 |
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial
|
Folschweiller, Nicolas
|
|
|
22 |
7 |
p. 1062-1075
|
artikel
|
| 33 |
Recognising group A streptococcal disease in pregnancy
|
Helmig, Rikke Bek
|
|
|
22 |
7 |
p. 928-929
|
artikel
|
| 34 |
Relapse in chronic pulmonary aspergillosis: more than what meets the eye?
|
Swain, Satish
|
|
|
22 |
7 |
p. 939-940
|
artikel
|
| 35 |
Relapse in chronic pulmonary aspergillosis: more than what meets the eye? – Authors' reply
|
Sehgal, Inderpaul S
|
|
|
22 |
7 |
p. 940-941
|
artikel
|
| 36 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
7 |
p. 953
|
artikel
|
| 37 |
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
|
Bager, Peter
|
|
|
22 |
7 |
p. 967-976
|
artikel
|
| 38 |
Robert Swenson
|
Bagcchi, Sanjeet
|
|
|
22 |
7 |
p. 954
|
artikel
|
| 39 |
Salmonella Typhimurium outbreak linked to chocolate
|
Samarasekera, Udani
|
|
|
22 |
7 |
p. 947
|
artikel
|
| 40 |
Screening and vaccination against COVID-19 to minimise school closure: a modelling study
|
Colosi, Elisabetta
|
|
|
22 |
7 |
p. 977-989
|
artikel
|
| 41 |
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
|
Sheikh, Aziz
|
|
|
22 |
7 |
p. 959-966
|
artikel
|
| 42 |
Spleen nodules in Loa loa infection: re-emerging knowledge and future perspectives
|
Tamarozzi, Francesca
|
|
|
22 |
7 |
p. e197-e206
|
artikel
|
| 43 |
Sustainability of surveillance systems for SARS-CoV-2
|
Adlhoch, Cornelia
|
|
|
22 |
7 |
p. 914-915
|
artikel
|
| 44 |
The Empress and the English Doctor
|
Burki, Talha
|
|
|
22 |
7 |
p. 958
|
artikel
|
| 45 |
The future of haemagglutinin stalk-based universal influenza vaccines
|
Isakova-Sivak, Irina
|
|
|
22 |
7 |
p. 926-928
|
artikel
|
| 46 |
The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2
|
Li, Jing-Xin
|
|
|
22 |
7 |
p. 916-917
|
artikel
|
| 47 |
Tracking the 2022 monkeypox outbreak with epidemiological data in real-time
|
Kraemer, Moritz U G
|
|
|
22 |
7 |
p. 941-942
|
artikel
|
| 48 |
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study
|
Ndjeka, Norbert
|
|
|
22 |
7 |
p. 1042-1051
|
artikel
|
| 49 |
Tsukamurella pneumonia misdiagnosed as pulmonary tuberculosis
|
Liu, Xiaojin
|
|
|
22 |
7 |
p. 1090
|
artikel
|
| 50 |
Vaccination plus previous infection: protection during the omicron wave in Brazil
|
Cerqueira-Silva, Thiago
|
|
|
22 |
7 |
p. 945-946
|
artikel
|
| 51 |
Vaccine Voyages: where science meets slavery
|
Ranscombe, Peter
|
|
|
22 |
7 |
p. 956
|
artikel
|
| 52 |
We need estimates of gonorrhoea vaccine protection and symptomaticity by sex and anatomical site
|
White, Peter J
|
|
|
22 |
7 |
p. 937
|
artikel
|
| 53 |
WHO Health For All film awards 2022
|
Balakrishnan, Vijay Shankar
|
|
|
22 |
7 |
p. 955
|
artikel
|
| 54 |
25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
|
Dean, Anna S
|
|
|
22 |
7 |
p. e191-e196
|
artikel
|
| 55 |
2 years of the Access to COVID-19 Tools-Accelerator
|
Balakrishnan, Vijay Shankar
|
|
|
22 |
7 |
p. 948
|
artikel
|
| 56 |
Yellow fever and immunocapitalism
|
Balakrishnan, Vijay Shankar
|
|
|
22 |
7 |
p. 957
|
artikel
|
Tijdschrift beschrijving